Showing results (11-20 of 31) with videos related to
Sort By:
Pageof 4
European Journal of Haematology|June 1, 2017
Emergence of Bruton's tyrosine kinase-negative Hodgkin lymphoma during ibrutinib treatment of chronic lymphocytic leukaemiaSiobhan Glavey, John Quinn, Mary McCloy, et al.Journal of Midwifery & Women'S Health|October 29, 2025
Innovative Teaching Approaches to Integrating Substance Use Disorder Training into Midwifery and Women's Health Nurse Practitioner Education ProgramsKirby Adlam, Erin Farah, Patrick Thornton, et al.Vaccine|June 1, 2014
The impact of pandemic A(H1N1)pdm09 influenza and vaccine-associated adverse events on parental attitudes and influenza vaccine uptake in young childrenChristopher C Blyth, Peter C Richmond, Peter Jacoby, et al.Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|February 20, 2020
Reasons Why Pregnant Women Participate in Ultrasound Research Involving Transvaginal ScansBarbara T Meagher, Marissa R Campos, Patrick Thornton, et al.Journal of Perinatal Medicine|July 12, 2014
Haemorrhagic and thrombotic complications in pregnant women with acquired and congenital cardiac diseaseBarry Kevane, Peter McKenna, Kevin Walsh, et al.Leukemia & Lymphoma|April 7, 2010
Large granular lymphocyte leukemia: natural history and response to treatmentAnne F Fortune, Kevin Kelly, Jeremy Sargent, et al.Birth (Berkeley, Calif.)|August 14, 2023
The birth center model of care: Staffing, business characteristics, and core clinical outcomesDiana R Jolles, Nancy Niemczyk, Lauren Hoehn Velasco, et al.Familial Cancer|August 9, 2014
Molecular heterogeneity of familial myeloproliferative neoplasms revealed by analysis of the commonly acquired JAK2, CALR and MPL mutationsStephen E Langabeer, Karl Haslam, Jennifer Linders, et al.Irish Journal of Medical Science|October 17, 2020
Biclonal lymphoproliferative disorders: another association with NOTCH1-mutated chronic lymphocytic leukaemiasHelen Fogarty, Anita Dowling, David O'Brien, et al.Frontiers in Oncology|July 15, 2022
TP53 Mutations Identified Using NGS Comprise the Overwhelming Majority of TP53 Disruptions in CLL: Results From a Multicentre StudyMark A Catherwood, Dorte Wren, Laura Chiecchio, et al.Pageof 4